IGF-1R blockade with ganitumab results in systemic effects on the GHIGF axis in mice
This clinical backing justifies premium positioning while delivering measurable consumer benefits
Composition: Aqua, Butylene Glycol, Glycerin, Japanese Koji Rice Ferment Filtrate, Caprylyl/Capryl Glucoside, Polyglyceryl-10 Isostearate, Sodium Dilauramidoglutamide Lysine, Silica, Sodium Acrylates Crosspolymer-2, Niacinamide, Glycolic Acid, Glutathione, Azadirachta Indica Leaf Extract, Glycyrrhiza Glabra Root Extract, Allantoin, Hydrolyzed Royal Jelly Protein, Disodium EDTA, Phenoxyethanol, Ethylhexylglycerin
Stay consistent with your foundational health habits
It can manifest as either abnormal fat distribution (lipohypertrophy) or loss of fat tissue (lipoatrophy), or a combination of both